The use of metformin in patients with chronic kidney disease

Journal Title: Annales Academiae Medicae Silesiensis - Year 2017, Vol 71, Issue

Abstract

Diabetes is a disease that affects about 4% of the population, and its incidence has been growing steadily. Increasingly more young people have to face this illness, and therefore more people suffer from chronic complications. The most frequent disorder of diabetics is diabetes nephropathy. This complication makes people‘s lives very difficult – not only the life of the patients but also the doctors who must strongly restrict the base of pharmaceuticals which can be used by these patients. Metformin has become a hope for people suffering from diabetes. This medicine has many advantages such as a decrease in glycaemia through many mechanisms. Simultaneously, it does not expose diabetics to hypoglycaemia. It reduces the death rate and protects patients‘ hearts. Additionally, it positively influences body weight, and it is taken orally. Currently, this medicine is also recommended in pre-diabetes states. Unfortunately, the chronic disease of the kidneys which usually occurs during diabetes does not enable the use of metformin. According to the Polish Diabetes Association, the dose of metformin should be reduced by half in the third phase of chronic kidney disease. In next phases, metformin should be thoroughly abandoned. There are opinions about the positive influence of metformin on people suffering from kidney disorders. The above article summarizes the current knowledge of using metformin and analyzes the latest research which describe its functioning. Additionally, it confronts two stances about the use of metformin in chronic kidney disease.

Authors and Affiliations

Michalina Mąka, Ewa Olszańska, Katarzyna Dubielak, Magdalena Domek

Keywords

Related Articles

Kto podróżuje w tym przedziale? Pomijane składniki żywności

Rośliny, włączając w nie zboża, warzywa, owoce i rośliny lekarskie, są konglomeratami współtworzonymi z mikroorganizmami (fitosfera) oraz mikro- i mezofauną, a typowy opis żywności nie odzwierciedla tej złożoności. Oblig...

Psychological gender among women involved in different forms of group physical activity

INTRODUCTION: Gender is a combination of psychological characteristics ascribed by culture to men or women. It is unrelated to biological sex but affects one’s experiences, reactions and behavior. The aim of the study wa...

State of prevention of eye diseases in selected group of children from Silesian Voivodeship – preliminary communication

BACKGROUND: Undiagnosed eye defects in childhood affect adult life and can cause irreversible changes. The aim of the study is to evaluate the state of preventing eye diseases in a selected group of children from the Sil...

Metatarsalgia as osteoarticular cause of foot dysfunction

Metatarsalgia – painful forefoot – is a term that refers to all metatarsal changes that have anatomical or biomechanical causes. The forefoot (the area extending between the metatarsophalangeal joint line and the tarsome...

Arterial blood pressure circadian rhythm in normotensive decompensated cirrhotic patients before and after single paracentesis

INTRODUCTION: Decompensated liver cirrhosis is associated with hemodynamic changes including arterial blood pressure alterations. The aim of the study was to investigate the circadian rhythm variability of arterial blood...

Download PDF file
  • EP ID EP344619
  • DOI 10.18794/aams/64312
  • Views 89
  • Downloads 0

How To Cite

Michalina Mąka, Ewa Olszańska, Katarzyna Dubielak, Magdalena Domek (2017). The use of metformin in patients with chronic kidney disease. Annales Academiae Medicae Silesiensis, 71(), 14-18. https://europub.co.uk/articles/-A-344619